Gabapentin 100mg 1000s
Gabapentin Capsule
Product Images NDC 50228-181
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50228-181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Gabapentin 100mg 100s
Gabapentin 100mg 30s
Each capsule contains 100 mg of gabapentin, USP. Gabapentin capsules are meant for prescription use only, and the usual dosage should be determined by the prescribing information. They should be stored in a temperature range of 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). Dispensing should be done in a tight container with a child-resistant closure, and medications should be kept out of the reach of children. This information is on packaging labeled with NDC 50228-179-30, with a revision date of 11/20. This medication guide should be provided to each patient when dispensing Gabapentin capsules. The manufacturer is Scieten Pramaceuticas, c., located in Hauppauge, NY 11788.*
Gabapentin 100mg 500cap
This is a medication called Gabapentin, which is available in capsule form. Each capsule contains 100mg of Gabapentin. There is also a note for pharmacists to provide a medication guide when dispensing Gabapentin capsules. The rest of the text is not legible.*
Gabapentin 300mg 30s
Gabapentin Capsules are available in the strength of 300mg per capsule. It is advised to store the medicine at a temperature of 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The medicine should be kept in a tight container with a child-resistant closure. Gabapentin Capsules should be dispensed after reading the accompanying prescribing information. It is important to provide a medication guide to each patient when dispensing Gabapentin Capsules. This medicine is only available on prescription and should be kept out of the reach of children. Manufacturing details of Gabapentin Capsules are mentioned in the given text.*
Gabapentin 300mg 1000cap
This seems to be a mixed text with some gibberish, not meaningful. The useful information seems to be related to a medication, specifically Gabapentin Capsules, made by a company named ScieGe, with NDC 50228-180-10. It also mentions that the pharmaceuticals company should provide a medication guide to each patient when dispensing Gabapentin Capsules. The rest of the text cannot be understood, a valid description is not available.*
Gabapentin 300mg 100cap
This is a description of a medication called Gabapentin. It comes in a 100-capsule bottle and is only available by prescription. The medication is manufactured by JscieGen and contains the active ingredient Gabapentin. The text also includes some numerical information (NDC 50228-180-01). Overall, the description is limited and does not provide detailed information about the medication's uses, side effects, or dosage instructions.*
Gabapentin Capsules, Usp 300 mg (500 capsules label)
Gabapentin 400mg 30s
Each capsule of Gabapentin USP contains 400mg of gabapentin. It is important to read the prescribing information before taking this medication, and to store it in a tight container with a child-resistant closure at 20° to 25°C (68° to 77°F). Excursions are permitted 10 to 15° to 30°C (59° to 86°F). Keep Gabapentin and all medications out of reach of children. The medication guide must be provided to each patient by the pharmacist when dispensing Gabapentin capsules. This medication is manufactured by Scieten Pramaceuticaks, C in Hauppauge, NY 11788.*
Gabapentin 400mg 100cap
Gabapentin Capsules, Usp 400 mg (500 capsules label)
Gabapentin 600mg 30s
Gabapentin tablets, USP each contain 600mg of gabapentin. They should be stored at 20° to 25°C (68° to 77°F) with excursions permitted 10° to 15°C to 30°C (59° to 86°F). The tablets should be dispensed in a tight container that has a child-resistant closure. It is essential to keep this medication and all others out of reach of children. It is necessary to read the accompanying prescribing information before using the medication. Gabapentin tablets, USP are available in a 30 tablet pack with NDC code 50228-177-30. This medicine can only be obtained through a prescription, and pharmacists must provide a medication guide for each patient when dispensing Gabapentin tablets. This item was made by Scieten Pramaceuticaks, c in Hauppauge, NY 11788.*
Gabapentin 600mg 100tab
Gabapentin Tablets, Usp 600 mg (500 Tablets label)
Gabapentin Tablets, USP, is a prescription medication used in treating seizures and nerve pain. The medication contains 600 mg of Gabapentin, USP, and comes in a bottle containing 500 tablets.*
Gabapentin 800mg 30s
Gabapentin tablets, USP are coated with film and contain 800 mg of gabapentin. The recommended dosage should be obtained from the attached prescribing information. The tablets should be stored at room temperature and in a container with a child-resistant closure. Pharmacist must provide medication guide to each patient. These tablets are prescription only and come in a container with 30 tablets. The manufacturer of the tablets is Scieten Pramaceuticaks, located in Hauppauge, NY 11788.*
Gabapentin 800mg 100tab
Gabapentin Tablets, Usp 800 mg (500 Tablets label)
Image 01
This appears to be a table displaying the mean pain score for two different dosing methods of a drug called "Parkod" over a period of weeks. The first dosing method is referred to as "Work Dose Titration" and the second is "Fixed Dose Period". The table includes a "Baseline" measurement and the drug is being compared to both a placebo and a drug called "Gabapentin" at a daily dose of 3600mg. However, without further context it is unclear what condition or ailment this study is focusing on.*
Image 02
The text describes a chart showing the results of a study in which participants received different doses of gabapentin or a placebo over a four-week period. The chart plots the mean pain scores of the participants at each week, and shows that higher doses of gabapentin were associated with lower pain scores compared to the placebo.*
Image 03
Cockcroft And Gault Equation (Image 04)
Gabapentin Structural Formula (Image 05)
Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
